Search clinical trials for: Insulin-only Bionic Pancreas

Total 49 results

Massachusetts General Hospital
Zealand Pharma; Beta Bionics, Inc.

Completed

The Bihormonal iLet Bionic Pancreas Feasibility Study

Type 1 Diabetes Mellitus

United States
Massachusetts General Hospital

Completed

The Insulin-Only Bionic Pancreas Bridging Study

Type1 Diabetes Mellitus

United States
Massachusetts General Hospital

Completed

The Monitoring Study

Type1diabetes

United States
Massachusetts General Hospital

Terminated

Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise

Type 1 Diabetes Mellitus

United States
Massachusetts General Hospital
Boston University

Completed

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Type 1 Diabetes

United States
Jaeb Center for Health Research
Boston University; Massachusetts General Hospital; National Institute of Diabetes... and other collaborators

Completed

The Insulin-Only Bionic Pancreas Pivotal Trial

Diabetes Mellitus | Diabetes Mellitus, Type 1 | Type 1 Diabetes

United States
Massachusetts General Hospital

Completed

The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study

Type1 Diabetes Mellitus

United States
Massachusetts General Hospital
Joslin Diabetes Center

Completed

Post Bariatric Closed Loop Glucagon Trial

Hypoglycemia

United States
Massachusetts General Hospital
Boston University

Completed

The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas

Type 1 Diabetes

United States
Massachusetts General Hospital
Boston University

Completed

A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas

Diabetes Mellitus Type 1

United States
Massachusetts General Hospital
Boston University

Completed

The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas

Type 1 Diabetes

United States
Massachusetts General Hospital
Boston University

Completed

Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas

Type 1 Diabetes

United States
Massachusetts General Hospital
Boston University

Terminated

Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

Type 1 Diabetes Mellitus

United States
Children's Hospital of Philadelphia
Boston University; Massachusetts General Hospital

Completed

Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes

Diabetes | Hyperinsulinism | Pancreatic Diseases | Pancreatectomy; Hyperglycemia

United States
Massachusetts General Hospital

Completed

The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes (SPT2D)

Type 2 Diabetes Mellitus

United States
Massachusetts General Hospital

Completed

The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance

Type 1 Diabetes | Type 2 Diabetes

United States
Zealand Pharma
Massachusetts General Hospital; Beta Bionics, Inc.

Completed

Feasibility Trial Testing the Bionic Pancreas With ZP4207 (dasiglucagon)

Diabetes Mellitus, Type 1

United States
University of Colorado, Denver
Massachusetts General Hospital; Beta Bionics, Inc.

Completed

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Diabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditions

United States
Massachusetts General Hospital
Beta Bionics, Inc.

Completed

Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes

Cystic Fibrosis-related Diabetes

United States
Massachusetts General Hospital
Boston University

Terminated

The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

Diabetes Mellitus Type 1

United States
Imperial College London

Completed

Clinical Assessment of a Closed-loop Insulin Delivery System

Type 1 Diabetes Mellitus

United Kingdom
Johns Hopkins University

Terminated

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
Nantes University Hospital

Unknown

Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study (PANCREAS)

Type 1 Diabetes

United States, Italy, Brazil, Czech Republic, France
J.H. DeVries
European Commission; Rijnstate Hospital

Completed

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format (APPEL4)

Diabetes Mellitus, Type 1

Netherlands
Sansum Diabetes Research Institute
Juvenile Diabetes Research Foundation

Completed

Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp

Type 1 Diabetes Mellitus

United States
Sansum Diabetes Research Institute
Mayo Clinic; Icahn School of Medicine at Mount Sinai; Harvard University

Completed

Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home

Type 1 Diabetes | Pregnancy

United States
Greet Van den Berghe

Active, not recruiting

Tight Glycemic Control With Intensive Insulin Therapy in PICU

Critical Illness

Belgium
Rabin Medical Center

Completed

Overnight MD-Logic

Type 1 Diabetes

Germany, Israel, Slovenia
Oregon Health and Science University

Completed

Three-way, Cross-over Closed-loop Exercise Study

Type 1 Diabetes

United States
Insulet Corporation

Completed

Insulet Artificial Pancreas Early Feasibility Study

Type 1 Diabetes

United States
University of Virginia
DexCom, Inc.; Tandem Diabetes Care, Inc.

Completed

Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp

Type 1 Diabetes Mellitus

United States
University of Virginia
DexCom, Inc.; Tandem Diabetes Care, Inc.

Completed

Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6

Type 1 Diabetes

United States
J.H. DeVries
Rijnstate Hospital; Inreda Diabetic B.V.

Completed

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, (APPEL5)

Diabetes Mellitus, Type 1

Netherlands
Air Liquide Santé International

Completed

Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Closed-loop Automatic Insulin Delivery System (SATURN)

Diabetes type1

France
Mount Sinai Hospital, Canada
Canadian Institutes of Health Research (CIHR); University of Toronto

Completed

Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL) (PREVAIL)

Type 2 Diabetes

Canada
Insulet Corporation

Completed

Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) (IDE2)

Type 1 Diabetes Mellitus

United States
Oregon Health and Science University

Completed

Single Hormone Closed Loop Study With PDT Sensor

Type 1 Diabetes Mellitus

United States
Oregon Health and Science University

Completed

Four Way Crossover Closed Loop With Exercise Detection

Type 1 Diabetes

United States
Oregon Health and Science University

Not yet recruiting

Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide

Type 1 Diabetes
Central Hospital, Nancy, France
Central Hospital, Reims, France; Central Hospital, Toulouse, France; Central... and other collaborators

Unknown

New Insulin Therapy by Multiwave Bolus (EVANEWFIT2)

Type1diabetes

France
University Hospital, Montpellier
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Recruiting

Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia (DCLP2)

Type 1 Diabetes Mellitus With Hypoglycemia

France
McGill University
Canadian Institutes of Health Research (CIHR)

Recruiting

Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

Diabetes Mellitus, Type 1 | Type 1 Diabetes | Postprandial Hyperglycemia

Canada
Boston University Charles River Campus
Massachusetts General Hospital; National Institute of Diabetes and Digestive... and other collaborators

Completed

Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas (CL2)

Diabetes Mellitus

United States
HaEmek Medical Center, Israel
Holy Family Hospital, Nazareth, Israel

Recruiting

Intrapartum Glucose and Insulin Compared to Glucose Alone in Diabetic Women

Pregnancy in Diabetics | Obstetric Labor

Israel
University Hospital, Montpellier

Active, not recruiting

Efficacy of Closed-loop Insulin Therapy in Prepubertal Child in Free-life (FREELIFE-KID)

Type 1 Diabetes Mellitus in Prepubertal Children

France
Sansum Diabetes Research Institute
University of California, Santa Barbara

Completed

Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)

Type 1 Diabetes Mellitus

United States
Institut de Recherches Cliniques de Montreal

Withdrawn

Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

Type 1 Diabetes Mellitus
Marmara University

Completed

The Effects of Tramadol Combined With Local Anesthesia on Pain After the Surgical Extraction of Third Molars

Pain After the Surgical Extraction of Third Molars
University of Portsmouth
University Hospital Southampton NHS Foundation Trust; Loughborough University; Queen Alexandra Hospital

Terminated

A CFit Study - Baseline

Cystic Fibrosis (CF) | Cystic Fibrosis-related Diabetes

United Kingdom

Search clinical trials for: Insulin-only Bionic Pancreas

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations